HomeInvestors HealthAstraZeneca's Imfinzi gains additional indication for bladder cancer AstraZeneca's Imfinzi gains additional indication for bladder cancer By BOMAR ENT. March 29, 2025 FacebookTwitterPinterestWhatsApp AstraZeneca's Imfinzi gains additional indication for bladder cancer Source link Previous articleRegression: Financial Insights with Excel & Python: Mastering Regression Analysis for Predictive Success (Python Libraries for Finance)Next articleReminiscences of a Stock Operator: With New Commentary and Insights on the Life and Times of Jesse Livermore (Annotated Edition) latest articles explore more Housing Market Shift: Inventory Catapults Back Think and Grow Rich JNJ forecasts 2025 profit dilution from Intra-Cellular deal, sets closing date Applied Spatial Statistics and Econometrics: Data Analysis in R (Routledge Advanced Texts in Economics and Finance) DC/AC Fundamentals: A Systems Approach Drug Tariffs Could Raise Cancer Treatment Cost By $10,000, Analysis Finds LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.